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Abstract
Scutellariae Radix is one of the well-known tocolytic Chinese herbs. Oroxylin A is isolated from
the root of Scutellaria baicalensis. The main syndrome of preterm birth is caused by uterus
contractions from excitatory factors. Administration of tocolytic agents is a strategy to prevent the
occurrence of preterm births. The aim of this study was to investigate the effects of oroxylin A on
contractions of uterine strips isolated from non-pregnant female Wistar rats (250~350 g).
Contractions of the uterus were induced with acetylcholine (Ach) (1 μM), PGF2α (0.1  μM),
oxytocin (10-3 U/ml), KCl (56.3 mM), tetraethylammonium (TEA; 1 and 10 mM), 4-aminopyridine
(4-AP; 5 mM), glipizide (30 μM), a nitric oxide synthase (NOS) inhibitor (LNNA; 10-3M), a β-
receptor blocker (propranolol; 10 μM), and a cyclooxygenase inhibitor (indomethacin; 60 μM). The
inhibitory effects of the amplitude and frequency of spontaneous contractions by oroxylin A were
antagonized with Ach (IC50 22.85 μM), PGF2α (IC5027.28 μM), oxytocin (IC50 12.34 μM), TEA; 1 and
10 mM (IC50 52.73 and 76.43 μM), 4-AP (IC50 67.16 μM), and glipizide (IC5027.53 μM), but oroxylin
A was not influenced by Ca2+-free medium, LNNA, propranolol, or indomethacin. Otherwise,
oroxylin A-mediated relaxation of the rat uterus might occur through opening of uterine calcium-
dependent potassium channels or adenosine triphosphate potassium channel activation. This
suggests that oroxylin A is the tocolytic principle constituent of Scutellariae Radix, and oroxylin A
may provide a lead compound for new tocolytic drug development in the future.
Background
After pregnancy, the endocrinology of the body of preg-
nant women obviously changes, including uterine con-
traction agonist receptors (such as oxytocin receptor,
prostaglandin receptor, β-adrenergic receptor, and corti-
cotrophin releasing hormone receptor), and ion channel
proteins which determine the resting membrane potential
and excitability of myocytes [1]. Dysfunctional uterine
contractions can lead to premature delivery. Spontaneous
preterm labo and delivery accounts for approximately
one-third of preterm births, which is the predominant
cause of prenatal mortality and morbidity. The wide range
of tocolytic agents in use is testament to the fact that we
still do not have an ideal drug available [2]. Therefore,
development of new safe and effective tocolytic agents is
an important research topic.
The Chinese herbs, Huang-Chi, Scutellaria baicalensis, has
been widely used to treat several diseases such as inflam-
mation, hypertension, suppressive dermatitis, diarrhea,
and pyrogenic infections [3]. Oroxylin A (5,7-dihydroxy-
6-methoxyflavone) is a flavonoid that is an active compo-
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nent isolated from the root of S. baicalensis. Several previ-
ous reports suggested that oroxylin A is a potential anti-
inflammatory agent [4]. It has suppressive effects on
superoxide and nitric oxide (NO) generation [5] and an
inhibitory effect on diclofenac 4-hydroxylation (CYP2C9)
activity [6]. In addition, it inhibits lipopolysaccharide-
induced inducible NO synthase (iNOS) and cyclooxygen-
ase (COX)-2 gene expression by suppressing nuclear fac-
tor-κB (NF-κB) activation [7,8], and it has also been
reported to suppress lymphocyte blastogenesis [9,10].
However, the effect of oroxylin A on the uterus is still
unknown. The tocolytic effect of oroxylin A is demon-
strated in the present study.
Materials and methods
Chemicals
Oxytocin, acetylcholine (Ach), (S)-(-) propranolol hydro-
chloride, dimethyl sulfoxide (DMSO), papaverine HCl,
tetraethylammonium (TEA), 4-aminopyridine (4-AP), gli-
pizide, and N-nitro-L-arginine (LNNA) were obtained
from Sigma Chemical(St. Louis, MO). Estradiol benzoate
was purchased from China Chemical & Pharmaceutical,
(city, Taiwan), and prostaglandine F2α(PGF2α) from Ono
Pharmaceutical (city, Japan). The stock solutions of all
drugs were diluted to the desired concentrations with a
physiological salt solution. Oroxylin A was isolated from
the root of S. baicalensis (Labiatae) obtained from Taipei
crude drug store and the structure is shown in Fig. 1.
Extraction and purification of oroxylin A from S. 
baicalensis
Oroxylin A was extracted from dried S. baicalensis. In brief,
dried  S.  baicalensis  roots were cut into small pieces,
immersed, and extracted with 10-fold v/w acetone twice at
room temperature for 2 weeks. After filtration, the resi-
dues were reflux-extracted with 4-fold v/w of 50% aque-
ous ethanol twice for 6 hours. The acetone extracts were
subjected to column chromatography on silica gel eluted
with CHCl3 and CHCl3-MeOH, and rechromatographed
on silica gel eluted with hexane-acetone to yield oroxylin
A. The compound was identified by direct comparison of
its electrospray ionization (ESI)-mass, 1H- and 13C-
nuclear magnetic resonance (NMR) spectroscopic data
with authentic samples. Purity tests of oroxylin A were
performed by high-performance liquid chromatography
(HPLC). The HPLC system consisted of a Shimadzu
model LC-10AT system (Kyoto, Japan) equipped with a
Shimadzu model SIL-9A autoautoinjector and a Shi-
madzu model SPD-10 A detector(Shimadzu, Kyoto,
Japan). Peak areas were calculated with a Shimadzu
model C-R8A recorder. A LiChrospher 100 RP-18e
reversed-phase column (Merck, Darmstadt, Ger-many)
and a LiChrospher 100 RP-18e guard column (Merck)
were used. The purity of all compounds exceeded 99.5%.
Animals
We used non-pregnant female Wistar rats weighing
250~350 g purchased from the Center of Experimental
Animals, National Taiwan University, Taipei, Taiwan. All
experiments were performed in accordance with guide-
lines for animal experiments of Taipei Medical University
and the guiding principles for the care and use of labora-
tory animals approved by the Chinese Society of Labora-
tory Animal Sciences, Taiwan. All efforts were made to
minimize animal suffering and to reduce the number of
animals used.
Isolation of rat uteri and contractility measurements in 
vitro
Animals were sacrificed by decapitation, and the uterine
horns were excised and cut into two halves (1 cm). The
uteri were immediately removed and placed in a flask con-
taining Locke solution of the following composition (in
mmol/L): NaCl 154, KCl 5.63, NaHCO3  1.79,
CaCl2·2H2O 2.55, and glucose 5.55. Experiments com-
menced within 5 min of removal of tissue samples. Prep-
arations were placed in isolated organ baths, incubated in
Locke's solution at 37 ± 1°C and bubbled with gas (95%
O2, 5% CO2). The preload was 1 g, and the equilibration
period was no less than 45 min [11]. The responses
induced were expressed as a percentage of the maximum
relaxation by papaverine (PPV; 10-3 M) which was added
at the end of each experiment. Contractions were recorded
by force displacement transducers (Kent Scientific Corpo-
ration, USA) using MP100 workstation software (Biopac
Systems, Inc, USA) on a PC.
Effect of oroxylin A on agonist-induced uterine 
contractions
A uterine strip was incubated in the Locke solution and
equilibrated for 30 min. Contractions were induced by
Ach (1 μM bath concentration), PGF2α (0.1 μM bath con-
centration), and oxytocin (10-3 U/ml bath concentration).
Oroxylin A isolated from Scutellaria baicalensis Figure 1
Oroxylin A isolated from Scutellaria baicalensis.
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Oroxylin A was added to the incubation solution and
allowed to react for 10 min before a more-concentrated
agent was added. Concentration-response curves of the
prescription (1~100 μm) were plotted against the phasic
response to Ach, PGF2α, and oxytocin. Control experi-
ments were performed with the vehicle (0.1% DMSO).
Effect of oroxylin A on oxytocin-induced Ca2+-free uterine 
contractions
Oxytocin-induced contractions in Ca2+-free medium: A
uterine horn was equilibrated for 1 h in Ringer-Locke
solution. The solution was then replaced with Ca2+-free
solution containing 3 mM EDTA, and incubation contin-
ued for 50 min. Subsequently, the solution was replaced
by a Ca2+-free solution containing 1 mM EDTA, and the
uterus was incubated for an additional 20~30 min. A sus-
tained contractile response to oxytocin (10-3 U/ml) was
obtained and cumulative concentrations of oroxylin A
were added.
Effect of oroxylin A on uterine contractions induced by K+ 
depolarization
The organ was immersed in Jalon-Ringer solution and
equilibrated for 20 min. This solution was replaced by a
depolarizing solution (KCl 56.3 mM) that caused a rapid
contraction, followed by slight relaxation and a prolonged
contraction plateau. When the plateau was reached,
cumulative concentrations of oroxylin A (1~100 μM)
were administered, and concentration-related relaxations
were observed.
Investigations on the involvement of potassium (K+) 
channels
In order to test the involvement of potassium channels in
the mechanism of action of oroxylin A, TEA (1 and 10
mM), 4-AP (a K blocker; 5 mM) and glipizide (KATP, 30
μM) were applied to the uterine strips 15 min prior to pre-
contraction by oxytocin (10-3 U/ml). The cumulative con-
centration-response curves of oroxylin A were then con-
structed and compared with those obtained with uterine
strips that had not been treated with these inhibitors.
Effects of a COX antagonist, NOS inhibitor, and  -
adrenergic antagonist on the relaxing effect
The uterine rings were induced by oxytocin and then incu-
bated for 15 min with indomethacin (a COX antagonist,
60 μM), L-NAME (an NOS inhibitor, 100 μM) and pro-
pranolol (a β-adrenoceptor antagonist, 10 μM). Oroxylin
A to be tested for antagonist activity was then added to the
bath and left in contact with the tissue for 10 min.
Statistical analysis
The results are expressed as the mean ± SE of several prep-
arations (n) from different animals. Agonists were added
until the steady, largest amplitudes were defined as the
maximal contractions. In accordance with the dose-
response curves, the concentration of oroxylin A produc-
ing 50% of the maximal contraction (IC50 value) was esti-
mated. Relaxation was expressed as a percentage of the
maximal contraction obtained by additing the agonist.
Statistical significance of differences between groups was
assessed using Student's t-test for unpaired data. p values
of < 0.05 were considered significantly different.
Results
Effects of oroxylin A on spontaneous contractions of the 
rat uterus
Application of oroxylin A, in a cumulative fashion, inhib-
ited spontaneous contractions of the rat uterus in a con-
centration-dependent manner, whereas the addition of
vehicle alone (0.1% DMSO) had no effect. The amplitude
of spontaneous uterine contractions significantly
decreased with 43.38 μm oroxylin A compared to the con-
trol.
Effects of oroxylin A on uterine contractions induced by 
agonists
Agonists, including PGF2α, oxytocin, and Ach, can induce
intense uterine contractions. We then examined the
effects of oroxylin A on uterine contractions induced by
these agonists. Oxytocin (10-3 U/ml), PGF2α (0.1 μM) and
Ach (1 μM) each significantly stimulated contractility. The
addition of oroxylin A inhibited uterine contractions
induced by three agonists. The inhibition by oroxylin A
increased with the concentrations added. The IC50 values
of oroxylin A on Ach, PGF2α, and oxytocin-induced con-
tractions were 22.85 μM, 27.28 μM, and 12.34 μM,
respectively. This indicates that oroxylin A was more sen-
sitive in inhibiting oxytocin-induced uterine contractions
(Fig. 2).
Effect of oroxylin A on oxytocin-induced uterine 
contractions in the Ca2+-free solution
The effect of the oroxylin A on oxytocin (10-3 U/ml)-
induced calcium release from smooth muscle in a solu-
tion without calcium on uterine contractions is shown in
oxytocin (10-3 U/ml) had no inhibitory effect on calcium
release from smooth muscle. It had an inducing effect, but
there was no statistical significance (Fig. 3).
Effect of oroxylin A on uterine contractions induced by K+ 
depolarization
The effect of oroxylin A on a high concentration of potas-
sium (KCl 56.3 mM)-induced uterine contractions was
examined. Oroxylin A had inhibitory effects on uterine
contractions induced by high potassium, and this also
showed a dose-response relationship. The IC50  of the
oroxylin A at 56.3 mM KCl was 12.58 μM. This indicates
that alterationsin the of membrane potential are involved
in the process of oroxylin A-induced uterine relaxation
(Fig. 4).Journal of Biomedical Science 2009, 16:27 http://www.jbiomedsci.com/content/16/1/27
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Effects of the potassium channel blockers, TEA, 4-AP, and 
glipizide on oroxylin A induced relaxation in uterine 
smooth muscle
Preincubation of uterine rings from rats with the nonspe-
cific potassium channel inhibitor, TEA (1 and 10 mM),
shifted the concentration-response curve of oroxylin A
and attenuated the relaxation activity induced by oroxylin
A (Fig. 5). Concentrations causing 50% of the inhibition
concentration were 52.73 μM and 76.43 μM in the pres-
ence of 1 and 10 mM TEA, respectively. The result indi-
cates that relaxation of oroxylin A is inhibited by TEA. In
the same part of the experiment, pretreatment of the uter-
ine muscle with other potassium channel inhibitors,
including 4-AP and glipizide, showed significant inhibi-
tion of oroxylin A-induced relaxation with IC50 values of
67.16 μM and 27.53 μM, respectively (Figs. 6, 7). Upon
comparison with the results of these potassium channel
antagonists, TEA appeared more effective than glipizide in
attenuating of oroxylin A-induced uterine relaxation.
Therefore, activation of potassium channels in the myo-
Effects of oroxylin A on contractions of rat uterus induced  by oxytocin (10-3 U/ml), PGF2α (0.1 μM), and Ach (1 μM) Figure 2
Effects of oroxylin A on contractions of rat uterus 
induced by oxytocin (10-3 U/ml), PGF2α (0.1 μM), and 
Ach (1 μM). Vertical bars represent the SEM (n = 4). *p < 
0.05, **p < 0.01.
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Effects of oroxylin A on contractions of rat uterus induced  by oxytocin (10-3 U/ml) in a Ca2+-free solution Figure 3
Effects of oroxylin A on contractions of rat uterus 
induced by oxytocin (10-3 U/ml) in a Ca2+-free solu-
tion. Vertical bars represent the SEM (n = 4).
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Effects of oroxylin A on tonic contractions of rat uterus  induced by KCl (56.3 mM) Figure 4
Effects of oroxylin A on tonic contractions of rat 
uterus induced by KCl (56.3 mM). Vertical bars repre-
sent the SEM (n = 4). *p < 0.05, **p < 0.01.
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Effects of the potassium channel inhibitor, tetraethylammo- nium (TEA; 1 and 10 mM), on oroxylin A-induced uterine  relaxation Figure 5
Effects of the potassium channel inhibitor, tetraethy-
lammonium (TEA; 1 and 10 mM), on oroxylin A-
induced uterine relaxation. Vertical bars represent the 
SEM (n = 4). *p < 0.05, **p < 0.01.
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metrium including Ca2+-dependent or ATP-dependent
potassium channels is involved in oroxylin A-induced
uterine relaxation.
-Adrenergic receptor, COX, and NO were not involved in 
oroxylin A-induced relaxation
In order to demonstrate the mechanism of oroxylin A-
induced uterine relaxation, pharmacological studies were
performed to study the roles that β-receptor, prostaglan-
din, and NO play in oroxylin A-induced uterine relaxa-
tion. A β-receptor blocker, propranolol, and a COX
inhibitor, indomethacin, and an NOS inhibitor, LNNA,
were added to the reaction followed by oroxylin A treat-
ment. The results revealed that propranolol, indometh-
acin, and LNNA showed no obvious effects on oroxylin A-
induced relaxation in oxytocin-precontracted uterine
muscle rings. We propose that activation of COX activity,
NO production, and the β-receptor might not be essential
in the process of oroxylin A-induced relaxation (Fig. 8).
Discussion
The results of the present study demonstrate that oroxylin
A, one of the major components of the Chinese herb, S.
baicalensis, exerted significant relaxative effects on sponta-
neous and agonist-induced uterine contractions. The
relaxation activity of oroxylin A was attenuated in KCl-
contracted uteri and blocked by the addition of TEA and
4-AP to the reaction; however netther L-NNA, propanolol,
nor indomethacin showed any effect on oroxylin A-
induced relaxation. These data indicate that potassium
channel activation is involved in oroxylin A-induced
relaxation. These results provide more scientific evidence
to support the traditional tocolytic effect of S. baicalensis
and demonstrate that oroxylin A might be its active com-
ponent, which deserves further clinical studies.
Cytoplasmic Ca2+ plays an important role in modulating
uterine contractions [12]. Previous studies demonstrated
that cytoplasmic Ca2+ can be regulated by intracellular
and extracellular Ca2+ pools, and agents inducing influx of
Ca2+ from extracellular spaces or increasing intracellular
Ca2+ by ER release cause uterine contractions. Those stud-
Effects of the potassium channel inhibitor, 4-aminopyridine  (4-AP), on oroxylin A-induced uterine relaxation Figure 6
Effects of the potassium channel inhibitor, 4-ami-
nopyridine (4-AP), on oroxylin A-induced uterine 
relaxation. Vertical bars represent the SEM (n = 4). *p < 
0.05, **p < 0.01.
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Effects of the potassium channel inhibitor, glipizide, on orox- ylin A-induced uterine relaxation Figure 7
Effects of the potassium channel inhibitor, glipizide, 
on oroxylin A-induced uterine relaxation. Vertical bars 
represent the SEM (n = 4). *p < 0.05, **p < 0.01.
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Effect of the propranolol (β-receptor blocker), indomethacin  (cyclooxygenase inhibitor) and L-NAME (NOS inhibitor) on  oroxylin A-induced uterine relaxation Figure 8
Effect of the propranolol (β-receptor blocker), 
indomethacin (cyclooxygenase inhibitor) and L-
NAME (NOS inhibitor) on oroxylin A-induced uter-
ine relaxation. Vertical bars represent the SEM (n = 4).
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ies indicated that Ca2+ is a critical mediator of uterine con-
tractions. In this study, oroxylin A showed a similar
relaxation pattern with or without Ca2+ in the reaction.
These data indicate that Ca2+ ion might not be an essential
factor in modulating oroxylin A-induced relaxation.
At lease three types of potassium ion currents have been
described in rat myometrium: a fast transient current and
two calcium-dependent noninactivating currents [13]. A
single-channel recording experiment revealed that large-
conductance calcium-dependent potassium channels
appear in the myometrium of both pregnant and non-
pregnant [14], and their activation results in cell hyperpo-
larization and suppression of the concentration of intrac-
ellular Ca2+. Therefore, a potassium channel opener is a
strong uterine relaxant.
Potassium channels are composed of diverse groups of
membrane channels including a voltage-dependent
potassium channel, a large-conductance Ca2+-dependent
potassium channel, and a small-conductance potassium
channel. Opening of potassium channels causes hyperpo-
larization of the plasma membrane by increasing potas-
sium conductance and reduces cell excitability by shifting
the membrane potential away from the threshold for exci-
tation [15]. To block potassium channels, we used two
nonselective potassium channel blockers, TEA, 4-AP, and
a selective ATP-dependent potassium channel blocker, gli-
pizide [16,17]. Oroxylin A-induced relaxation of the
uterus was completely blocked by TEA, 4-AP, and glipiz-
ide. These data indicate activation of potassium channels
in the myometrium including Ca2+-dependent or ATP-
dependent potassium channels is involved in oroxylin A-
induced uterine relaxation.
NO is a unique and ubiquitous biological second messen-
ger, and several studies have demonstrated that NO is an
important regulatory molecule in uterine contractions
during pregnancy. The action of NO in the uterus is
believed to consist of maintaining myometrial quiescence
during the period of pregnancy, and a decreased amount
of NO was seen in uterine smooth muscle in the period
near labor and delivery [18,19]. Therefore, NO is an essen-
tial factor in the process of pregnancy. In this study, the
NOS inhibitor, LNNA, did not suppress the relaxation
activity of oroxylin A in oxytocin-precontracted uterine
muscle. This result indicates that modulation of NO pro-
duction might not be involved in oroxylin A-induced uter-
ine relaxation.
Prostaglandins have been reported to be mediators of the
regulation of the contraction status during pregnancy and
parturition. Prostaglandin synthesis is controlled by two
rate-limiting enzymes, phospholipase A2 and COX. Two
distinct isoforms of COX, COX-1 and COX-2, have been
identified. Previous reports demonstrated that inhibition
of COX was able to suppress abnormal contractions in the
uterus. However, Araslan A et al. demonstrated that inhi-
bition of COX by indomethacin caused a risk of neonatal
cerebral hemorrhage and necrotizing enterocolitis [20].
Therefore, the role COX plays in uterus is controversial. In
the present study, Indomethacin showed no effect on
oroxylin A-induced relaxation. This suggests that COX is
not involved in oroxylin A-induced relaxation.
Although oroxylin A will most likely never be used clini-
cally to achieve tocolysis, the data presented here clearly
demonstrate that oroxylin A is able to relax pregnant rat
myometrium through a mechanism involving activation
of potassium channels. The results showed that TEA, 4-AP,
and glipizide effectively blocked oroxylin A-induced uter-
ine relaxation. This study demonstrates that the tocolytic
effect might be attributable to the opening of uterine cal-
cium-dependent potassium channels or action on ATP-
dependent potassium channels. These results indicate that
the examined plant possesses direct uterine relaxation
activity which can justify oroxylin A usage in traditional
herbal remedies during prematurity. This preliminary
study has shown that plant extracts should now be sub-
jected to procedures to characterize the pharmacologically
active principle, with a view to identifying a novel target
site through which to achieve tocolysis.
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